Scarica l'app Stockscreener
310.96
2.87%
8.68
Dopo l'orario di chiusura:
311.75
0.79
+0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LRCX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$302.28
Aprire:
$296.815
Volume 24 ore:
9.28M
Relative Volume:
0.86
Capitalizzazione di mercato:
$389.11B
Reddito:
$21.68B
Utile/perdita netta:
$6.71B
Rapporto P/E:
58.69
EPS:
5.298
Flusso di cassa netto:
$6.00B
1 W Prestazione:
+14.80%
1M Prestazione:
-0.97%
6M Prestazione:
+36.17%
1 anno Prestazione:
+135.22%
Intervallo 1D:
$296.08
$311.39
Intervallo di 1 settimana:
$265.75
$311.39
Portata 52W:
$125.02
$438.50
Lam Research Corp Stock (LRCX) Company Profile
Nome
Lam Research Corp
Settore
Industria
Telefono
(510) 659-0200
Indirizzo
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
310.96 | 373.17B | 21.68B | 6.71B | 6.00B | 5.298 |
ASML
Asml Holding Nv
|
1,747.90 | 652.32B | 41.20B | 12.41B | 11.15B | 32.12 |
AMAT
Applied Materials Inc
|
472.46 | 362.27B | 29.02B | 8.51B | 5.34B | 10.64 |
KLAC
Kla Corp
|
188.32 | 236.01B | 13.09B | 4.67B | 4.01B | 3.5373 |
TER
Teradyne Inc
|
398.69 | 59.37B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-05-18 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2026-05-05 | Iniziato | Seaport Research Partners | Buy |
| 2026-04-02 | Downgrade | Erste Group | Buy → Hold |
| 2026-01-29 | Aggiornamento | Summit Insights | Hold → Buy |
| 2026-01-29 | Reiterato | TD Cowen | Buy |
| 2026-01-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-01-15 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Reiterato | TD Cowen | Buy |
| 2025-09-30 | Iniziato | HSBC Securities | Hold |
| 2025-09-29 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Ripresa | Erste Group | Buy |
| 2025-07-31 | Downgrade | Summit Insights | Buy → Hold |
| 2025-07-31 | Reiterato | TD Cowen | Buy |
| 2025-07-10 | Iniziato | Goldman | Buy |
| 2025-04-24 | Reiterato | TD Cowen | Buy |
| 2025-03-20 | Ripresa | Oppenheimer | Outperform |
| 2025-02-20 | Aggiornamento | Susquehanna | Neutral → Positive |
| 2025-01-30 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Iniziato | Cleveland Research | Neutral |
| 2024-08-01 | Reiterato | TD Cowen | Buy |
| 2024-05-13 | Iniziato | Jefferies | Buy |
| 2024-04-25 | Reiterato | TD Cowen | Buy |
| 2024-04-19 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Reiterato | Needham | Buy |
| 2024-04-16 | Iniziato | Evercore ISI | Outperform |
| 2024-04-11 | Ripresa | Deutsche Bank | Hold |
| 2024-01-25 | Reiterato | TD Cowen | Outperform |
| 2024-01-23 | Iniziato | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Iniziato | Redburn Atlantic | Buy |
| 2023-10-17 | Iniziato | Raymond James | Outperform |
| 2023-10-13 | Aggiornamento | Needham | Hold → Buy |
| 2023-09-15 | Iniziato | Wolfe Research | Outperform |
| 2023-07-24 | Reiterato | Mizuho | Buy |
| 2023-07-24 | Aggiornamento | Stifel | Hold → Buy |
| 2023-04-20 | Reiterato | Berenberg | Buy |
| 2023-04-20 | Reiterato | Evercore ISI | Outperform |
| 2023-04-20 | Reiterato | JP Morgan | Overweight |
| 2023-04-20 | Reiterato | Jefferies | Buy |
| 2023-04-20 | Reiterato | Mizuho | Buy |
| 2023-04-20 | Reiterato | Stifel | Hold |
| 2023-04-20 | Reiterato | Wells Fargo | Equal Weight |
| 2023-03-13 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Ripresa | Stifel | Hold |
| 2022-12-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Reiterato | B. Riley Securities | Neutral |
| 2022-10-20 | Reiterato | BofA Securities | Buy |
| 2022-10-20 | Reiterato | DA Davidson | Neutral |
| 2022-10-20 | Reiterato | Evercore ISI | Outperform |
| 2022-10-20 | Reiterato | JP Morgan | Overweight |
| 2022-10-20 | Reiterato | Jefferies | Buy |
| 2022-10-20 | Aggiornamento | Summit Insights | Hold → Buy |
| 2022-10-20 | Reiterato | Wells Fargo | Equal Weight |
| 2022-07-25 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Reiterato | Barclays | Overweight |
| 2022-01-27 | Reiterato | Deutsche Bank | Hold |
| 2022-01-27 | Reiterato | Evercore ISI | Outperform |
| 2022-01-27 | Reiterato | Stifel | Buy |
| 2022-01-27 | Reiterato | Susquehanna | Neutral |
| 2022-01-27 | Reiterato | UBS | Buy |
| 2022-01-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Reiterato | Barclays | Overweight |
| 2022-01-10 | Reiterato | BofA Securities | Buy |
| 2022-01-05 | Ripresa | Jefferies | Buy |
| 2021-12-15 | Reiterato | Deutsche Bank | Hold |
| 2021-10-21 | Reiterato | B. Riley Securities | Buy |
| 2021-10-21 | Downgrade | Summit Insights | Buy → Hold |
| 2021-10-15 | Iniziato | Piper Sandler | Neutral |
| 2021-09-14 | Downgrade | Susquehanna | Positive → Neutral |
| 2021-09-07 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Reiterato | Mizuho | Buy |
| 2021-07-29 | Reiterato | Stifel | Buy |
| 2021-07-29 | Reiterato | UBS | Buy |
| 2021-07-29 | Reiterato | Wells Fargo | Equal Weight |
| 2021-03-31 | Iniziato | Bernstein | Outperform |
| 2021-01-28 | Reiterato | Cowen | Outperform |
| 2021-01-08 | Downgrade | Needham | Buy → Hold |
| 2020-12-17 | Downgrade | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Reiterato | Goldman | Buy |
| 2020-10-22 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Reiterato | Mizuho | Buy |
| 2020-10-22 | Reiterato | Morgan Stanley | Overweight |
| 2020-10-22 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-10-22 | Reiterato | Stifel | Buy |
| 2020-10-22 | Reiterato | UBS | Buy |
| 2020-09-21 | Aggiornamento | Stifel | Hold → Buy |
| 2020-07-30 | Reiterato | Cowen | Outperform |
| 2020-07-21 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Downgrade | Stifel | Buy → Hold |
| 2020-06-16 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Iniziato | Barclays | Overweight |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-04-08 | Iniziato | Exane BNP Paribas | Outperform |
| 2020-04-03 | Aggiornamento | Nomura | Neutral → Buy |
| 2020-04-02 | Downgrade | DA Davidson | Buy → Neutral |
| 2020-03-27 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Aggiornamento | UBS | Sell → Buy |
Mostra tutto
Lam Research Corp Borsa (LRCX) Ultime notizie
Lam Research Corporation Share PriceLRCX, RNS News, Articles, Quotes, & Charts (NASDAQ:LRCX) - Proactive financial news
Lam Research Lifts 2026 WFE Outlook as AI Demand Strains Fab Capacity - Yahoo Finance
Lam Research Corporation $LRCX Shares Acquired by The Manufacturers Life Insurance Company - MarketBeat
Lam Research stock heads into the open after a 5.6% drop - ad-hoc-news.de
Lam Research stock heads into the open after a 5.7% drop - ad-hoc-news.de
Lam Research Corp (LRCX) Shares Fall 5.7% -- What GF Score of 85 Tells Investors - GuruFocus
Lam Research CEO Timothy Archer sells $9.58 million in company stock By Investing.com - Investing.com Australia
Here's How Much $100 Invested In Lam Research 20 Years Ago Would Be Worth Today - Benzinga
Lam Research CEO Timothy Archer sells $9.58 million in company stock - Investing.com Australia
Lam Research Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Lam Research director Bethany Mayer sells $3m in shares By Investing.com - Investing.com South Africa
Lam Research director Bethany Mayer sells $3m in shares - investing.com
Lam Research at Goldman Sachs conference: demand stays red hot By Investing.com - Investing.com UK
Lam Research (NASDAQ: LRCX) CEO exercises options and sells 30,000 shares - Stock Titan
Lam Research (NASDAQ: LRCX) director sells shares with no preset trading plan disclosed - Stock Titan
AXT Stock Falls 22% in Three Months: 3 Reasons the Dip Looks Attractive - Zacks Investment Research
Lam Research Corp Stock (LRCX) Opened Down by 3.98% on Sep 10: What Signal Does It Send? - TradingKey
Lam Research Returns $5B+ to Shareholders in FY26: Can It Reward More? - Yahoo Finance
Lam Research (LRCX) Benefits From Memory Expansion - Yahoo Finance
Rench Wealth Management Inc. Trims Stake in Lam Research Corporation $LRCX - MarketBeat
IFP Advisors Inc Acquires 4,186 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research stock heads into the open after a Nasdaq-led drop - ad-hoc-news.de
Lam Research stock heads into the open after a 1.4 percent drop - ad-hoc-news.de
Lam Research (LRCX) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Lam Research (NASDAQ: LRCX) director lines up 2026 stock sale - Stock Titan
Lam Research Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Lam Research at Citi’s 2026 Global TMT Conference: ai demand lifts outlook - Investing.com India
Lam Research Corporation at Citi Global TMT Conference Transcript - GuruFocus
Third 30,000-share Lam Research (NASDAQ: LRCX) stock sale planned by Timothy Archer - Stock Titan
How are broader market themes affecting Lam Research (NASDAQ:LRCX) today? - Kalkine Media
SVB Wealth LLC Sells 6,059 Shares of Lam Research Corporation $LRCX - MarketBeat
Integrated Wealth Concepts LLC Sells 5,061 Shares of Lam Research Corporation $LRCX - MarketBeat
NewEdge Advisors LLC Purchases 34,079 Shares of Lam Research Corporation $LRCX - MarketBeat
Sterling Investment Advisors Ltd. Makes New $1.64 Million Investment in Lam Research Corporation $LRCX - MarketBeat
Baird Financial Group Inc. Sells 9,182 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Insider Sold Shares Worth $9,577,800, According to a Recent SEC Filing - Moomoo
Applied Materials, AMD, Broadcom, Lam Research, and Marvell Technology Shares Skyrocket, What You Need To Know - Yahoo Finance
Waverly Advisors LLC Has $40.69 Million Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
3,249 Shares in Lam Research Corporation $LRCX Acquired by CORDA Investment Management LLC. - MarketBeat
Lam Research Corp (LRCX) Shares Surge 4.2% -- What GF Score of 8 - GuruFocus
Lam Research (NASDAQ:LRCX) Shares Up 4.2%Time to Buy? - MarketBeat
Lam Research Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Lam Research (NASDAQ:LRCX): What’s Fueling the Buzz? - Kalkine Media
Lam Research Corp Stock (LRCX) Moved Up by 3.79% on Sep 8: What Investors Need To Know - TradingKey
Is Lam Research (LRCX) Stock Outpacing Its Computer and Technology Peers This Year? - Yahoo Finance
Lam Research (NASDAQ:LRCX) faces a fresh market test as trading resumes today - Kalkine Media
Ameritas Advisory Services LLC Boosts Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Nearly Triples in a Year: Is the Stock Still Worth Buying? - Yahoo Finance
Lam Research stock heads into the open after a 5.1 percent jump - ad-hoc-news.de
HB Wealth Management LLC Sells 7,369 Shares of Lam Research Corporation $LRCX - MarketBeat
Munich Reinsurance Co Stock Corp in Munich Has $18.28 Million Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp Azioni (LRCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lam Research Corp Azioni (LRCX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ARCHER TIMOTHY | President and CEO |
Sep 09 '26 |
Sale |
319.26 |
30,000 |
9,577,800 |
1,075,966 |
| Mayer Bethany | Director |
Sep 09 '26 |
Sale |
314.74 |
9,557 |
3,007,970 |
20,995 |
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):